- Home
- EXAS vs LCID Comparison
EXAS vs LCID Comparison
Compare EXAS & LCID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- LCID
- Stock Information
- Founded
- EXAS 1995
- LCID 2007
- Country
- EXAS United States
- LCID United States
- Employees
- EXAS N/A
- LCID N/A
- Industry
- EXAS Medical Specialities
- LCID Auto Manufacturing
- Sector
- EXAS Health Care
- LCID Consumer Discretionary
- Exchange
- EXAS Nasdaq
- LCID Nasdaq
- Market Cap
- EXAS 10.5B
- LCID 9.0B
- IPO Year
- EXAS N/A
- LCID N/A
- Fundamental
- Price
- EXAS $49.26
- LCID $3.06
- Analyst Decision
- EXAS Strong Buy
- LCID Hold
- Analyst Count
- EXAS 17
- LCID 9
- Target Price
- EXAS $72.31
- LCID $3.18
- AVG Volume (30 Days)
- EXAS 1.9M
- LCID 76.8M
- Earning Date
- EXAS 02-19-2025
- LCID 02-25-2025
- Dividend Yield
- EXAS N/A
- LCID N/A
- EPS Growth
- EXAS N/A
- LCID N/A
- EPS
- EXAS N/A
- LCID N/A
- Revenue
- EXAS $2,758,867,000.00
- LCID $730,510,000.00
- Revenue This Year
- EXAS $12.09
- LCID $34.40
- Revenue Next Year
- EXAS $11.24
- LCID $83.62
- P/E Ratio
- EXAS N/A
- LCID N/A
- Revenue Growth
- EXAS 10.37
- LCID 4.98
- 52 Week Low
- EXAS $40.62
- LCID $1.93
- 52 Week High
- EXAS $79.62
- LCID $4.43
- Technical
- Relative Strength Index (RSI)
- EXAS 33.51
- LCID 52.19
- Support Level
- EXAS $45.94
- LCID $3.24
- Resistance Level
- EXAS $51.75
- LCID $3.59
- Average True Range (ATR)
- EXAS 2.13
- LCID 0.20
- MACD
- EXAS -0.30
- LCID 0.04
- Stochastic Oscillator
- EXAS 32.20
- LCID 44.21
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About LCID Lucid Group Inc.
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.